Pharmacologic testing of the reversibility of an increased pulmonary vascular resistance (PVR) with prostaglandin E1 (PGE1) before heart transplantation (HTX): final results of the multicenter prophet study

Follow-up (days) 389.7 329.8 404.4 396.8 S NYHA (functional class) 3.5 0.5 3.3 0.5 N 2.7 0.6 3.4 0.6 0.001 S VO2max (ml O2/kgr/min) 9.7 3.4 10.6 3.3 N 12.9 5.1 8.0 4.2 0.01 S PAS (mm Hg) 62.3 16.2 62.6 16.8 N 51.2 17.4 69.9 15.8 0.001 S PAM (mm Hg) 41.8 11.7 41.9 10.8 N 35.2 10.9 45.0 13.4 0.01 S PCW (mm Hg) 28.1 8.1 26.9 6.7 N 25.4 9.3 28.5 8.8 NS S TPG (mm Hg) 13.7 6.9 15.9 7.0 N 9.9 4.4 17.0 7.3 0.001 S